SK Biopharmaceuticals, the drug manufacturing affiliate of SK Group, is struggling despite brisk sales of its epilepsy drug cenobamate, data showed Monday. The epilepsy drug sold under the brand names Xcopri in the U.S. and Ontozry in the European Union, is a medication used to treat the partial-onset of seizures in adults.
Aragen Life Sciences, a global research, development, and manufacturing solutions provider (CRO/CDMO), announced that it has signed a definitive agreement to acquire Pune-based Intox Pvt. Ltd. This acquisition will expand Aragen’s end-to-end integrated discovery and development platform for the pharmaceuticals, biotechnology, animal health and agrochemicals industries.